ARTHROGEN B V has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are VAXIN INC, ZBiotics Company and NANJING SINOGEN BIOTECH & PHARMACEUTICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Finn Jonathan D | 8 |
#2 | Vervoordeldonk Margarita Jacoba Bernadetta Maria | 5 |
#3 | Tak Paul-Peter | 5 |
#4 | Grimm Dirk | 2 |
#5 | Finn Jonathan Douglas | 2 |
#6 | Jonathan D Finn | 1 |
#7 | Margarita Jacoba Bernadetta Maria Vervoordeldonk | 1 |
#8 | Broekstra Niels | 1 |
#9 | Snoek Susanne Anna | 1 |
#10 | Börner Kathleen | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016055437A1 | Aav-based gene therapy | |
WO2014003553A1 | Combination for treating an inflammatory disorder |